The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 2, pp. 175-177.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mason, B.
Right arrow Articles by Blackburn, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason, B.
Right arrow Articles by Blackburn, K.


Research Articles

Possible serotonin syndrome associated with tramadol and sertraline coadministration

BJ Mason and KH Blackburn

OBJECTIVE: To report a possible case of serotonin syndrome associated with coadministration of tramadol hydrochloride and sertraline hydrochloride. CASE SUMMARY: A 42-year-old woman developed atypical chest pain, sinus tachycardia, confusion, psychosis, sundowning, agitation, diaphoresis, and tremor. She was taking multiple medications, including tramadol and sertraline. The tramadol dosage had recently been increased, resulting in what was believed to be serotonergic syndrome. DISCUSSION: Serotonin syndrome is a toxic hyperserotonergic state that develops soon after initiation or dosage increments of the offending agent. Patients may differ in their susceptibility to the development of serotonin syndrome. The (+) enantiomer of tramadol inhibits serotonin uptake. Tramadol is metabolized to an active metabolite, M1, by the CYP2D6 enzyme. If this metabolite has less serotonergic activity than tramadol, inhibition of CYP2D6 by sertraline could have been a factor in the interaction. CONCLUSIONS: Clinicians should be aware of the potential for serotonin syndrome with concomitant administration of sertraline and tramadol.


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. Patroneva, S. M. Connolly, P. Fatato, R. Pedersen, Q. Jiang, J. Paul, C. Guico-Pabia, J. A. Isler, M. E. Burczynski, and A. I. Nichols
An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects
Drug Metab. Dispos., December 1, 2008; 36(12): 2484 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
M. SPINK, S. BAHN, and R. GLICKMAN
Clinical implications of cyclo-oxygenase-2 inhibitors for acute dental pain management: Benefits and risks
J Am Dent Assoc, October 1, 2005; 136(10): 1439 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. MAHLBERG, D. KUNZ, J. SASSE, and J. KIRCHHEINER
Serotonin Syndrome With Tramadol and Citalopram
Am J Psychiatry, June 1, 2004; 161(6): 1129 - 1129.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. J Houlihan
Serotonin Syndrome Resulting from Coadministration of Tramadol, Venlafaxine, and Mirtazapine
Ann. Pharmacother., March 1, 2004; 38(3): 411 - 413.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. B. Turkel, J. G. B. Nadala, and M. Z. Wincor
Possible Serotonin Syndrome in Association With 5-HT3 Antagonist Agents
Psychosomatics, June 1, 2001; 42(3): 258 - 260.
[Abstract] [Full Text]




homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.